Latest news with #ACOs
Yahoo
24-06-2025
- Business
- Yahoo
Koan Health Renews NCQA Data Aggregator Validation Certification
Population health analytics leader continues commitment to data integrity and quality measures in value-based care. DALLAS, June 24, 2025 /PRNewswire/ -- Koan Health, a leading population health analytics company, announced today that it has once again earned the Certified Data Partner designation through the National Committee for Quality Assurance (NCQA) Data Aggregator Validation (DAV) program. The repeat certification reflects Koan Health's continued commitment to delivering high-quality clinical data that meets the rigorous standards of accuracy, integrity, and security set by NCQA. "Our clients rely on us to make sense of complex data, and we don't take that trust lightly," said DT Nguyen, Founder and CEO of Koan Health. "Earning this certification again underscores our unwavering commitment to data accuracy and transparency. At Koan, we understand that when clinical data integrity is accurate, everything else—insights, quality performance, and outcomes—can follow." The DAV certification applies to Koan Health's comprehensive population health analytics platform that supports ACOs, CINs, payers, and other risk-bearing organizations. Data partners that earn validation undergo a comprehensive, end-to-end evaluation of their quality and integrity, from ingestion through delivery to end users. Validation ensures adherence to NCQA's extracting standards and supports the trustworthy use of clinical data in quality programs like HEDIS®. The renewed certification comes as healthcare organizations face increasing pressure to demonstrate measurable outcomes in value-based care arrangements. Koan Health's Datalyst™ platform enables accountable providers to leverage powerful analytics to understand their networks, provider performance, and quality metrics, helping organizations quickly identify opportunities to improve clinical and financial results. About Koan Health Koan Health is a population health analytics company serving ACOs, CINs, payers, and other risk-bearing organizations in value-based care relationships. Through the Datalyst™ platform, providers leverage powerful analytics to understand networks, performance, and quality metrics to improve clinical and financial results. For more information, visit About NCQA NCQA is a private, nonprofit organization dedicated to improving healthcare quality. NCQA accredits and certifies a wide range of healthcare organizations. It also recognizes clinicians and practices in key areas of performance. NCQA's Healthcare Effectiveness Data and Information Set (HEDIS®) is the most widely used performance measurement tool in healthcare. Learn more at View original content to download multimedia: SOURCE Koan Health Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
11-06-2025
- Yahoo
50 cats, 22 dogs found living in neglect at 2 Kentucky homes
DAVIESS COUNTY, Ky. (FOX 56) — The Daviess County Sheriff's Office is investigating a pair of animal cruelty cases after roughly 50 cats were found covered in feces and urine on Monday. According to a press release, on June 9, authorities were called to a home on the 10,000 block of Kentucky Highway 56 as well as a home in the 500 block of Sycamore Street to investigate reports of animal cruelty and neglect. 50 cats, 22 dogs found living in neglect at 2 Kentucky homes Ukrainian children seek hope, healing in Lexington amid ongoing war Work set to begin in July for Lexington's 3rd Publix: What to know At the home on KY 56, animal control officers found approximately 50 cats living there with inadequate food and water. ACOs described the home as 'unsanitary' and riddled with animal feces and urine. In the release, officials said the cats were showing signs of neglect, and some were near death. The cats were taken to It Takes A Village animal rescue in Owensboro for treatment. The animal rescue took to Facebook to ask for donations, foster homes, and possible cat adoption. DCSO said the homeowners were charged with second-degree cruelty to animals. According to the release, 22 dogs lived in unsanitary conditions at the Sycamore Street home. Read more of the latest Kentucky news Investigators claimed that the dogs were showing signs of neglect, and the area wasn't large enough for that many dogs. In the press release, the sheriff's office claimed the homeowner was issued a criminal summons concerning a previous animal cruelty investigation. Authorities said that the investigation is ongoing and charges are pending. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
11-06-2025
- Business
- Yahoo
HEALWELL AI Leverages Orion Health to Power Entry into US Market
HEALWELL launches in the U.S. market a suite of AI enabled tools to complement Orion Health's established software offerings in the U.S. This will bring together HEALWELLs globally validated AI capabilities with Orion Health's best-in-class health data infrastructure software creating a unique offering for the U.S. market. This U.S. market launch leverages Orion Health's deep U.S. sector experience, existing U.S. footprint and multi-decade track record of delivering health data infrastructure software to customers in eight U.S. states. US digital-health market spend reached $160.4 billion in 2024 and is forecast to grow at a 15.4% CAGR from 2025 to 2033 to reach $695.2 billion by 20331. As the U.S. healthcare sector is the largest globally; HEALWELL views the U.S. market as a key jurisdiction of focus. Toronto, Ontario--(Newsfile Corp. - June 11, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce a strategic expansion into the U.S. healthcare market, aligning the group's direction following its acquisition of Orion Health. This move marks a major milestone in HEALWELL's mission to advance preventative care through AI-driven insights and trusted health data infrastructure. With over two decades of experience in the U.S, Orion Health has built a strong foundation supporting health information exchanges (HIEs), accountable care organizations (ACOs), clinically integrated networks (CINs), payers, and health systems. Its technology powers clinical data exchange across eight states, enabling thousands of clinicians to access health information for millions of patients, every day. This embedded presence will give HEALWELL immediate reach and credibility in one of the world's largest and most complex healthcare environments. To support this strategic expansion, HEALWELL has established dedicated U.S. and Canadian teams, reflecting the distinct regulatory, funding, and market dynamics of each region. "Orion has had a material presence in the USA for over two decades," said Brad Porter, Chief Commercial Officer at HEALWELL. "We now have a unique opportunity to accelerate value for our customers by combining Orion's trusted platform with HEALWELL's next-generation AI capabilities. The robust clinical validation and data lineage features differentiates these tools in the market and ultimately reduces friction with regards to clinical adoption." HEALWELL's U.S. strategy will focus on the delivery of value-based care and population health initiatives through two critical capabilities: health data infrastructure and a suite of AI-enabled tools to be made available as a compelling offering to ACOs, CINs, HIEs, payers and health systems. As regulatory frameworks like TEFCA along with convergence of standards towards FHIR reshape the national data landscape, HEALWELL is introducing a modular, FHIR-native repository to work alongside Orion's robust HL7-based data repository. This approach enables a TEFCA-ready, standards-aligned architecture that supports longitudinal patient records, interoperability, and real-time data sharing, while providing a clear upgrade path for existing HIEs and provider networks. Complementing this foundation is HEALWELL's growing suite of AI tools which will be introduced to the market, including AI-enabled clinical search, AI-enabled clinical summarisation and AI-enabled patient identification and risk stratification. These tools are designed to integrate seamlessly into existing clinical infrastructure, helping care teams surface insights faster, reduce administrative burden, and improve clinical outcomes. "The demand for clinically validated and explainable AI is growing fast," said Dr. Alexander Dobranowski, CEO of HEALWELL. "Our ability to embed these tools into existing systems rather than replace them means we can drive impact quickly, without disrupting workflows." To deepen its U.S. market presence, HEALWELL will also focus on strategic partnerships and M&A. Dr. Dobranowski adds, "As highlighted by our track record, we will be continuing to evaluate U.S. oriented partnerships, acquisition opportunities and organic expansion to ensure capital allocation matches the ambition of HEALWELLs purpose of enabling the adoption of AI driven preventative care." Beyond providers and public health systems, HEALWELL also sees growing demand from the life sciences sector, where real-world evidence (RWE) generation, decentralized clinical trial orchestration, and identifying gaps in patient care are increasingly common. With established life sciences partnerships and a platform built for scalability, HEALWELL is well-positioned to support clinical research, clinical development, and outcomes-based engagement in the U.S. market. HEALWELL's subsidiaries Pentavere and Khure Health have an established track record with U.S. life sciences and health system organizations and are currently commercially active with 7 of the top 10 largest pharmaceutical companies globally. "We're seeing real traction and a path to significant growth," said James Lee, incoming CEO of HEALWELL. "We're making excellent progress on integration and go-to-market plans, and we're seeing significant opportunities to both expand responsibly and rationalize expenses to improve operating margins. We're at the start of the curve in proving how AI can improve patient outcomes and help healthcare systems become more targeted with their resources. It's an exciting time for the industry." HEALWELL's U.S. oriented portfolio of capabilities will include HEALWELL Data as a Service, a FHIR complaint data store and a growing suite of AI-enabled tools that support clinical search, patient clinical summarisation, patient identification and patient risk stratification. These capabilities complement Orion Health's established and scaled U.S. offerings, including Amadeus Digital Care Record, Virtuoso Digital Front Door, and Communicate Direct Secure Messaging, creating an integrated platform that will deliver both infrastructure and intelligence to the frontlines of care. Dr. Alexander DobranowskiChief Executive OfficerHEALWELL AI Inc. 1 About HEALWELL HEALWELL is a healthcare artificial intelligence company focused on preventative care. Its mission is to improve healthcare and save lives through early identification and detection of disease. Using its own proprietary technology, the Company is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases, improve efficiency of their practice and ultimately help improve patient health outcomes. HEALWELL is executing a strategy centered around developing and acquiring technology and clinical sciences capabilities that complement the Company's road map. HEALWELL is publicly traded on the Toronto Stock Exchange under the symbol "AIDX" and on the OTCQX Market under the symbol "HWAIF". To learn more about HEALWELL, please visit Forward-Looking Statements Certain statements in this press release, constitute "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities laws, including statements about the potential for HEALWELL and Orion Health to develop new products and services, or to enhance or combine existing ones, and the anticipated impact of such products and services; and the anticipated timing, focus and implementation of Healwell's strategic expansion into the U.S. Market; and are based on assumptions, expectations, estimates and projections as of the date of this press release. Forward-looking statements are often, but not always, identified by words or phrases such as "mission", "opportunity", "introducing", "is engaging", "continue to", "improve" or variations of such words and phrases or statements that certain future conditions, actions, events or results "will", "may", "could", "would", "should", "might" or "can" be taken, occur or be achieved, or the negative of any of these terms . Forward-looking statements are necessarily based upon management's perceptions of historical trends, current conditions and expected future developments, as well as a number of specific factors and assumptions that, while considered reasonable by HEALWELL as of the date of such statements, are outside of HEALWELL's control and are inherently subject to significant business, economic and competitive uncertainties and contingencies which could result in the forward-looking statements ultimately being entirely or partially incorrect or untrue. Forward-looking statements contained in this press release are based on various assumptions, including, but not limited to, the following: HEALWELL's ability to integrate Orion Health personnel, products, services, customers and relationships; HEALWELL's and Orion Health's ability to maintain and leverage their relationships with their commercial partners; the continued adoption of the software, tools and solutions created by HEALWELL and its subsidiaries; that HEALWELL will be successful in identifying, executing and integrating new acquisitions, investments and/or partnerships, the stability of general economic and market conditions; sufficiency of working capital and access to financing; HEALWELL's ability to comply with applicable laws and regulations; HEALWELL's continued compliance with third party intellectual property rights; the effects of competition in the industry; the requirement for increasingly innovative product solutions and service offerings; technologies working as intended or at all; trends in customer growth and the adoption of new technologies in the industry; and that the risk factors noted below, collectively, do not have a material impact on HEALWELL's business, operations, revenues and/or results. By their nature, forward-looking statements are subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections, or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved. Known and unknown risk factors, many of which are beyond the control of HEALWELL, could cause the actual results of HEALWELL to differ materially from the results, performance, achievements, or developments expressed or implied by such forward-looking statements. Such risk factors include but are not limited to those factors which are discussed under the section entitled "Risk Factors" in HEALWELL's most recent annual information form dated March 31, 2025, which is available under HEALWELL's SEDAR+ profile at The risk factors are not intended to represent a complete list of the factors that could affect HEALWELL and the reader is cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements are provided for the purpose of providing information about management's expectations and plans relating to the future. HEALWELL disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, or to explain any material difference between subsequent actual events and such forward-looking statements, except to the extent required by applicable law. All of the forward-looking statements contained in this press release are qualified by these cautionary statements. For more information: Pardeep S. SanghaInvestor Relations, HEALWELL AI 604-572-6392ir@ To view the source version of this press release, please visit Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Business Wire
21-05-2025
- Health
- Business Wire
Health Endeavors, Telescope Health Advancing Provider Analytics and Care Gap Solutions Through Strategic Partnership
FARMINGTON, Utah--(BUSINESS WIRE)--Healthcare technology leaders Health Endeavors and Telescope Health are partnering to provide comprehensive, value-based solutions for health systems, physician groups, Clinically Integrated Networks (CINs), and Accountable Care Organizations (ACOs). This innovative technology will help the healthcare ecosystem optimize performance and close care gaps through actionable data, while also providing a platform designed to meet the needs of diverse patient populations. 'This partnership accelerates and expands the analytics and actionable data that we can provide to our value-based care partners and providers at the point of care. This will help lead to better performance, improved access and better care for individual patients,' stated David Derrick, CEO of Health Endeavors. The two organizations are transforming raw data into insights to help providers evaluate their performance, establish market transparency, review Quality Scores, calculate aggregate costs, collect population health metrics and more. It will also offer personalized, virtual care resources to supplement providers' existing efforts. 'Our passion for reducing barriers to care complements perfectly with Health Endeavors' mission of using data to empower not only the provider, but the patient as well,' said Telescope Health CEO and Co-Founder Dr. Matthew Thompson. 'This collaboration represents a concerted effort to identify where the gaps are and empower providers with the necessary tools to improve how they serve their patients.' The partnership is rooted in Health Endeavors' decades-long experience providing analytic and quality support to value-based care partners. Telescope Health, a physician-led technology company focused on improving health care outcomes, has served hundreds of thousands of patients through a diverse portfolio of providers, employers, non-profits and local governments. For more information on how Health Endeavors and Telescope Health are impacting health care through advanced technology, please visit About Health Endeavors Recognized as a thought leader, Health Endeavors has a long history of supporting Accountable Care Organizations (ACO) and those in value-based care arrangements. With proprietary augmented intelligence Health Endeavors analyzes segregated data and transforms it into actionable insights. These insights are then delivered directly at the point of care, empowering your providers with the necessary tools to win. The mission is simple: return resources, power, and joy back to the point of care. Learn more at About Telescope Health Telescope Health is a physician-led technology company focused on improving healthcare outcomes. We serve public, private and nonprofit organizations as well as individuals seeking on-demand, comprehensive care and actionable data insights. To learn how we're doing that every day, visit
Yahoo
20-05-2025
- Business
- Yahoo
Healthcare Industry Shifts to Value-Based Reimbursement as New Standard
Value-based reimbursement is now the norm for ACOs and physician practices, highlighting the vital role of CDI specialists, medical coders, and utilization management in improving care and reimbursement. The rise of AI in clinical documentation urges CDI providers to innovate for next-gen healthcare workflows. Dublin, May 20, 2025 (GLOBE NEWSWIRE) -- The "Clinical Documentation Integrity in North America, 2025: Frost Radar Report" report has been added to the healthcare industry shifts from a fee-for-service to a fee-for-value model, value-based reimbursement is becoming the standard for accountable care organizations (ACOs), independent physician practices, and non-ACO entities. This transition underscores the essential role of clinical documentation integrity (CDI) specialists, medical coders, and utilization management staff in enhancing care personalization; mitigating adverse events, such as medication reconciliation errors; and improving reimbursement efficiency. CDI, which is an integral part of revenue cycle management, is a strategic imperative in healthcare, extending beyond its role in claims processing and denials management. It enhances patient outcomes, ensures data accuracy to reflect the true care narrative, supports precise reimbursement, and strengthens compliance risk management and revenue integrity. As new-age CDI vendors prioritize the adoption of cutting-edge technology, such as conversational AI, AI clinical assistant in medical coding, and the use of ambient AI in clinical documentation and machine learning and natural language processing in autonomous coding, it has become imperative for electronic health record-based and legacy CDI providers to stay competitive and redefine their clinical documentation tools to support next-generation workflows across the healthcare Topics Covered: Clinical Documentation Integrity in North America, 2025 Strategic Imperative and Growth Environment Companies to Action AGS Health Amazing Charts Arintra Greenway Health Iodine Software Microsoft Optum Oracle Health Provation Solventum Waystar Best Practices & Growth Opportunities Next Steps: Leveraging the Radar to Empower Key Stakeholders For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
